Delivery Order SPE2DP20D0002-SPE2DP20F5512
Award Date 6/17/20
Potential Completion Date 6/23/20
Potential Value $271K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Wales, PA 19454, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The contract is a firm-fixed price Delivery Order with a potential value of $135,747.00 and a completion date of July 28, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that manufactures a range of drug products, including vaccines, for U.S. government...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Teva Pharmaceuticals USA, Inc. for the delivery of Adenovirus Type 4 vaccines. The $135,747.00 contract has an August 25, 2020 completion date. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit manufacturer that has provided a range of pharmaceutical products, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $282,353.76 contract has an April 27, 2021 completion date and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that has supplied various pharmaceutical products, including vaccines, antiviral medications, respiratory...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The $271,494.00 firm fixed-price contract has a completion date of July 28, 2020. This award is not associated with a set-aside program. Teva Pharmaceuticals USA, Inc. has previously provided various pharmaceutical products, including vaccines, antiviral medications,...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The Firm Fixed Price contract has a potential value of $135,747.00 and a completion date of November 17, 2020. It was awarded on November 3, 2020, and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract is a firm-fixed-price delivery order with a potential value of $271,494.00 and a completion date of December 15, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that has provided various pharmaceutical products, including vaccines, antiviral...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the supply of Adenovirus Type 4 vaccine, a critical product for military immunization programs. The $158,804.73 firm-fixed-price contract has a period of performance through March 26, 2024. Teva Pharmaceuticals USA, Inc. has been awarded numerous prime federal contracts and delivery orders from...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024 and does not utilize a set-aside designation. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $476,414.19 firm-fixed-price delivery order to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime contracts by federal agencies such as the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The contract has a firm fixed price of $423,530.64 and a completion date of February 23, 2021. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that produces a range of drug products, including vaccines, for U.S. government agencies like the Department of Defense...
- SPE2DP20D0002Indefinite Delivery Contract
- SPE2DP20D0002-SPE2DP20F5512Delivery Order
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The contract is a $271,494 firm-fixed price delivery order with a completion date of June 23, 2020. Teva Pharmaceuticals USA, Inc. is a for-profit, foreign-owned organization that has previously supplied pharmaceutical products including vaccines, antivirals, and respiratory treatments to government agencies such as the Department of Defense and Department of Veterans Affairs. The contract does not have a set-aside designation.
Generated 3/23/24, 4:29 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
ADENOVIRUS TYPE 4 A | SPE2DP18R01130009 | Defense Logistics Agency Troop Support Medical | Award Notice 1/1 | 2/3/20, 2:02 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $271.5k | 6/17/20 |